MedTrace Logo

Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents

NCT03507205 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17286

Last updated 2026-04-27

No results posted yet for this study

Summary

The objective of this study is to evaluate the long-term efficacy and safety of coronary stenting with the various types of drug-eluting stents (DES) and to determine clinical device and procedural success during commercial use of DES in the real world.

The investigators will compare EES (Xience V/Promus and Xience Prime), SES (Cypher), ZES (Resolute Integrity, Endeavor Resolute, Endeavor), and BES (Biomatrix, Biomatrix Flex, and Nobori).

Conditions

Interventions

DEVICE

Biomatrix; Biomatrix Flex; Nobori

Biodegradable polymer-coated biolimus-eluting stents

DEVICE

Xience Prime

Durable polymer-coated everolimus-eluting stents

DEVICE

Xience V/Promus; Cypher

Durable polymer-coated everolimus-eluting stents; Sirolimus-eluting stents

DEVICE

DP-ZES-RI

Durable polymer-coated zotarolimus-eluting stents

DEVICE

Endeavor; Resolute

Durable polymer-coated zotarolimus-eluting stents

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Hyo-Soo Kim, MD, PhD · Seoul National University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-01
Primary Completion
2017-11-01
Completion
2017-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03507205 on ClinicalTrials.gov